Enochian Biosciences Inc. (ENOB) NASDAQ
$0.70 - (-)
Market Cap: $40.80M
As of 08/04/23 12:00 AM EDT. Market closed.
Enochian Biosciences Inc. (ENOB)
NASDAQ
$0.70
- (-)
Market Cap: $40.80M
As of 08/04/23 12:00 AM EDT. Market closed.
Add to Portfolio
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and cancer. the company’s lead candidate eno-1001 (pre-ind) is a potentially sterilizing cure for hiv/aids. eno-2001 is an hiv vaccine in preclinical stage, and its additional ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$313,775
CEO Compensation (Total)
$426,612
URL
Address
Century City Medical Plaza, 2080 Century City East, California, Los Angeles, 90067.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Eric Leire
CEO Compensation (Base)
$313,775
CEO Compensation (Total)
$426,612
Address
Century City Medical Plaza, 2080 Century City East, California, Los Angeles, 90067.
PRICE CHART FOR ENOCHIAN BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.72
Previous Close
$0.70
Days Range
$0.70 - $0.75
52 week range
$0.39 - $2.99
Volume
88,381
Avg. Volume (30 days)
436,764
Market Cap
$40.80M
Dividend Yield
-
P/E
-
Shares Outstanding
58,283,591
Open
$0.72
Previous Close
$0.70
Days Range
$0.70 - $0.75
52 week range
$0.39 - $2.99
Volume
88,381
Avg. Volume (30 days)
436,764
Market Cap
$40.80M
Dividend Yield
-
P/E
-
Shares Outstanding
58,283,591
FINANCIAL STATEMENTS FOR ENOCHIAN BIOSCIENCES INC
LOADING...
INSIDER TRANSACTIONS FOR ENOCHIAN BIOSCIENCES INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Sindlev Rene | Director | Feb 20, 2024 | Option Exercise | $0.53 | 471,699 | 250,000 | 13,605,297 | Feb 22, 2024, 04:35 PM |
Sindlev Rene | Director | Jun 26, 2023 | Option Exercise | $0.53 | 1,886,794 | 1,000,001 | 12,432,338 | Jun 27, 2023, 08:29 PM |
Sindlev Rene | Director | Mar 17, 2023 | Option Exercise | $1.14 | 877,193 | 1,000,000 | 10,545,544 | Mar 21, 2023, 09:39 PM |
Gumrukcu Serhat | 10% Owner | May 18, 2022 | Sale | $8.00 | 253,493 | 2,027,944 | 12,401,552 | May 20, 2022, 09:37 PM |
Sindlev Rene | Director | May 18, 2022 | Buy | $8.00 | 128,493 | 1,027,944 | 128,493 | May 20, 2022, 09:32 PM |
Sindlev Rene | Director | May 18, 2022 | Buy | $8.00 | 125,000 | 1,000,000 | 125,000 | May 20, 2022, 09:32 PM |
Sandler Carl Forest | Director | Mar 22, 2022 | Sale | $9.06 | 1,927 | 17,459 | 3,187,487 | Mar 24, 2022, 04:30 PM |
Sandler Carl Forest | Director | Feb 23, 2022 | Sale | $9.00 | 6 | 54 | 3,189,414 | Feb 23, 2022, 05:18 PM |
Sandler Carl Forest | Director | Feb 18, 2022 | Sale | $9.03 | 6,792 | 61,348 | 3,189,420 | Feb 23, 2022, 05:18 PM |
Sindlev Rene | Director | Jul 30, 2019 | Option Exercise | $1.30 | 3,092,307 | 4,019,999 | 9,668,351 | Aug 01, 2019, 09:26 PM |
Sindlev Rene | Director | Jun 04, 2019 | Buy | $6.70 | 31,500 | 211,050 | 6,576,044 | Jun 06, 2019, 02:26 PM |
Sindlev Rene | Director | May 28, 2019 | Buy | $6.61 | 36,200 | 239,282 | 6,484,544 | Jun 05, 2019, 02:08 PM |
Sindlev Rene | Director | Jun 03, 2019 | Buy | $6.70 | 40,000 | 268,000 | 6,544,544 | Jun 05, 2019, 02:07 PM |
Sindlev Rene | Director | May 29, 2019 | Buy | $6.60 | 20,000 | 132,000 | 6,504,544 | Jun 05, 2019, 02:06 PM |
Sindlev Rene | Director | May 24, 2019 | Buy | $6.25 | 5,014 | 31,338 | 6,448,344 | Jun 05, 2019, 02:05 PM |
Sindlev Rene | Director | May 28, 2019 | Buy | $6.61 | 36,200 | 239,282 | 6,479,530 | May 30, 2019, 04:05 PM |
Sindlev Rene | Director | May 22, 2019 | Buy | $5.76 | 500 | 2,880 | 6,443,330 | May 24, 2019, 03:39 PM |
Sindlev Rene | Director | May 21, 2019 | Buy | $5.75 | 20,000 | 115,000 | 6,442,830 | May 23, 2019, 05:39 PM |
Gronfeldt-Sorensen Henrik | Director | Jan 10, 2019 | Buy | $2.00 | 50,000 | 100,000 | 50,000 | Jan 11, 2019, 05:37 PM |
Sindlev Rene | Director | Dec 27, 2018 | Buy | $8.00 | 92,968 | 743,744 | 5,115,137 | Dec 28, 2018, 07:11 PM |
Sindlev Rene | Director | Dec 27, 2018 | Option Exercise | $1.30 | 1,307,693 | 1,700,001 | 6,422,830 | Dec 28, 2018, 07:11 PM |
Sindlev Rene | Director | Feb 16, 2018 | Option Exercise | $1.44 | 1,250,000 | 1,800,000 | 5,020,869 | Nov 07, 2018, 09:13 PM |
Sindlev Rene | Director | May 21, 2018 | Buy | $5.38 | 1,300 | 6,994 | 5,022,169 | Nov 07, 2018, 09:13 PM |
Leire, Eric Jean Marie | Chief Executive Officer | May 17, 2018 | Buy | $5.40 | 754 | 4,072 | 72,246 | Jun 04, 2018, 04:50 PM |
Leire, Eric Jean Marie | Chief Executive Officer | May 16, 2018 | Buy | $5.50 | 190 | 1,045 | 71,492 | Jun 04, 2018, 04:50 PM |
Leire, Eric Jean Marie | Chief Executive Officer | May 24, 2018 | Buy | $5.27 | 700 | 3,691 | 73,246 | Jun 04, 2018, 04:50 PM |
Leire, Eric Jean Marie | Chief Executive Officer | May 22, 2018 | Buy | $5.25 | 300 | 1,575 | 72,546 | Jun 04, 2018, 04:50 PM |
Leire, Eric Jean Marie | Chief Executive Officer | Sep 20, 2017 | Option Exercise | $1.80 | 62,687 | 112,837 | 71,302 | Sep 22, 2017, 04:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ENOCHIAN BIOSCIENCES INC
STOCK BUYBACKS FOR ENOCHIAN BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
0.84%
1Q
09/30/2022
1.59%
2Q
06/30/2022
5.74%
3Q
03/31/2022
6.34%
4Q
12/31/2021
6.98%
5Q
09/30/2021
7.19%
6Q
06/30/2021
15.42%
7Q
03/31/2021
19.65%
8Q
12/31/2020
19.96%
9Q
09/30/2020
20.10%
10Q
06/30/2020
20.42%
11Q
03/31/2020
20.96%
12Q
12/31/2019
20.96%
13Q
09/30/2019
21.05%
14Q
06/30/2019
43.53%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ENOCHIAN BIOSCIENCES INC
LOADING...